Table 2.
Percentage of involved sites in the curcumin and triamcinolone groups
Involved site | Curcumin (n=25) | Triamcinolone (n=25) | Total (n=50) |
---|---|---|---|
Buccal | 10 (20%) | 8 (16%) | 18 (36%) |
Gingiva of maxilla | 7 (14%) | 9 (18%) | 16 (32%) |
Gingiva of mandible | 2 (4%) | 4 (8%) | 6 (12%) |
Tongue | 2 (4%) | 1 (2%) | 3 (6%) |
Palate | 1 (2%) | 2 (4%) | 3 (6%) |
Labial mucosa | 1 (2%) | 1 (2%) | 2 (4%) |
Floor of the mouth | 2 (4%) | 0 | 2 (4%) |